-
Je něco špatně v tomto záznamu ?
Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency
H Hassoun, JN Vassiliadis, J Murray, PR Njolstad, JJ Rogus, SK Ballas, F Schaffer, P Jarolim, V Brabec, J Palek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu práce podpořená grantem, Research Support, U.S. Gov't, P.H.S.
Grantová podpora
IZ4118
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
ROAD: Directory of Open Access Scholarly Resources
PubMed
9207476
Knihovny.cz E-zdroje
- MeSH
- dědičná sférocytóza * genetika metabolismus MeSH
- komplementární DNA genetika MeSH
- lidé MeSH
- posunová mutace MeSH
- rodokmen MeSH
- spektrin genetika nedostatek MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Research Support, U.S. Gov't, P.H.S. MeSH
Several subsets of patients with hereditary spherocytosis (HS) have been defined based on the specific red blood cell membrane protein deficiencies involving spectrin, ankyrin, band 3, and protein 4.2. Mutations of the genes encoding these proteins are currently being uncovered. Regarding spectrin, only three isolated cases of beta-spectrin gene mutations were recently reported in association with HS and spectrin deficiency. We have screened the coding region of the beta-spectrin gene using the SSCP technique, in 40 families with HS associated with spectrin deficiency or combined spectrin and ankyrin deficiencies. In this report we describe six frameshift and nonsense mutations and four missense mutations of the beta-spectrin gene in 11 unrelated families. Taking advantage of modifications in the restriction enzyme recognition sequences introduced by the mutations, we show, in all cases of frameshift and nonsense mutations, the loss of heterozygosity at the cDNA level when compared to genomic DNA, reflecting the absence of the mutant mRNA transcripts. In one family with a large pedigree including six generations and 112 members, we firmly establish the autosomal dominant inheritance of one of the beta-spectrin null mutations. Most of the mutations described are responsible for a phenotype of mild to moderate autosomal dominant form of HS associated with a conspicuous spherocytosis with frequent spiculated cells (8% to 15% acanthocytes). One missense mutation appears to be associated with a recessive form of the disease. Five common restriction enzyme polymorphisms of the coding region of the beta-spectrin gene are also described. Overall, these findings underscore the importance of the beta-spectrin gene mutations in the pathogenesis of HS and reemphasizes the extreme heterogeneity of the underlying molecular basis of this condition.
Department of Pediatrics and Medical Genetics Haukeland University Hospital Bergen Norway
Harvard School of Public Health Program for Population Genetics Cambridge MA
Institute of Hematology and Blood Transfusion Prague Czech Republic
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14061857
- 003
- CZ-PrNML
- 005
- 20140627140034.0
- 007
- ta
- 008
- 140617s1997 xxua f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)9207476
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hassoun, H. $u Department of Biomedical Research, St Elizabeth's Medical Center of Boston, Tufts University Medical School, MA 02135, USA
- 245 10
- $a Characterization of the underlying molecular defect in hereditary spherocytosis associated with spectrin deficiency / $c H Hassoun, JN Vassiliadis, J Murray, PR Njolstad, JJ Rogus, SK Ballas, F Schaffer, P Jarolim, V Brabec, J Palek
- 504 __
- $a Literatura
- 520 9_
- $a Several subsets of patients with hereditary spherocytosis (HS) have been defined based on the specific red blood cell membrane protein deficiencies involving spectrin, ankyrin, band 3, and protein 4.2. Mutations of the genes encoding these proteins are currently being uncovered. Regarding spectrin, only three isolated cases of beta-spectrin gene mutations were recently reported in association with HS and spectrin deficiency. We have screened the coding region of the beta-spectrin gene using the SSCP technique, in 40 families with HS associated with spectrin deficiency or combined spectrin and ankyrin deficiencies. In this report we describe six frameshift and nonsense mutations and four missense mutations of the beta-spectrin gene in 11 unrelated families. Taking advantage of modifications in the restriction enzyme recognition sequences introduced by the mutations, we show, in all cases of frameshift and nonsense mutations, the loss of heterozygosity at the cDNA level when compared to genomic DNA, reflecting the absence of the mutant mRNA transcripts. In one family with a large pedigree including six generations and 112 members, we firmly establish the autosomal dominant inheritance of one of the beta-spectrin null mutations. Most of the mutations described are responsible for a phenotype of mild to moderate autosomal dominant form of HS associated with a conspicuous spherocytosis with frequent spiculated cells (8% to 15% acanthocytes). One missense mutation appears to be associated with a recessive form of the disease. Five common restriction enzyme polymorphisms of the coding region of the beta-spectrin gene are also described. Overall, these findings underscore the importance of the beta-spectrin gene mutations in the pathogenesis of HS and reemphasizes the extreme heterogeneity of the underlying molecular basis of this condition.
- 536 __
- $c Grant Number: HL27215 (United States NHLBI NIH HHS)
- 536 __
- $c Grant Number: HL37462 (United States NHLBI NIH HHS)
- 536 __
- $c Grant Number: K08 HL02720 (United States NHLBI NIH HHS)
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a komplementární DNA $x genetika $7 D018076
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a posunová mutace $7 D016368
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a rodokmen $7 D010375
- 650 02
- $a spektrin $x genetika $x nedostatek $7 D013049
- 650 12
- $a dědičná sférocytóza $x genetika $x metabolismus $7 D013103
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, P.H.S. $7 D013487
- 700 1_
- $a Vassiliadis, J. N. $u Department of Pediatrics and Medical Genetics, Haukeland University Hospital, Bergen, Norway
- 700 1_
- $a Murray, J. $u Harvard School of Public Health, Program for Population Genetics, Cambridge, MA
- 700 1_
- $a Njolstad, P. R. $u Department of Medicine, Cardeza Foundation for Hematologie Research, Jefferson Medical College, Philadelphia, PA
- 700 1_
- $a Rogus, J. J. $u Department of Pediatrics at Temple University School of Medicine, St Christopher's Hospital for Children, Philadelphia, PA
- 700 1_
- $a Ballas, S. K.
- 700 1_
- $a Schaffer F.
- 700 1_
- $a Jarolím, Petr, $d 1955- $7 jn20000710077 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Brabec, Václav, $d 1925- $7 xx0073920 $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 700 1_
- $a Palek J $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic
- 773 0_
- $t Blood $x 0006-4971 $g Roč. 90, č. 1 (1997), s. 398-406 $p Blood $w MED00000807
- 773 0_
- $p Blood $g 90(1):398-406, 1997 Jul 1 $x 0006-4971
- 910 __
- $a ABA008 $b B 405 $c 315 $y 4 $z 0
- 990 __
- $a 20140617162339 $b ABA008
- 991 __
- $a 20140627140308 $b ABA008
- 999 __
- $a ok $b bmc $g 1029227 $s 860517
- BAS __
- $a 3
- BMC __
- $a 1997 $b 90 $c 1 $d 398-406 $x MED00000807 $i 0006-4971 $m Blood $n Blood
- GRA __
- $a IZ4118 $p MZ0
- LZP __
- $a 2014-06/gvbo